Has Tom Ghobrial, MD received payments from drug or device companies?

Yes. Drug and device makers reported $160 in general payments to Tom Ghobrial, MD across 9 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tom Ghobrial, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tom Ghobrial, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tom Ghobrial, MD

Orthopedic Surgery · Cumberland, MDNPI 1518928746

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Medtronic at 48.1% of the total. Reporting peaked in 2019 at $52 and has fallen 73.2% since, to $14 in 2025. That places this record below the midpoint for orthopedic surgery clinicians in MD, where the typical reported total is $622.

$160in general payments, 2019–2025

Across 9 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$77
Pacira Therapeutics, Inc.$41
Acelrx Pharmaceuticals, Inc.$31
Omeros Corporation$11

What the payments were for

Food & beverage$160100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	4	$77
Pacira Therapeutics, Inc.	2	$41
Acelrx Pharmaceuticals, Inc.	2	$31
Omeros Corporation	1	$11

How this compares

$160 in reported general payments places this provider in the 40th percentile of 24 orthopedic surgery providers in Maryland.

See all orthopedic surgery providers in Maryland →

Medicare billing

Part B allowed, 2024

$245,384

Medicare patients

357

Services billed

1,377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Amoxicillin	61	$49

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Cumberland

Christopher CannovaBethesda$1.6M
Craig MillerBethesda$72K
Jason KinneyBaltimore$22K
Mark PetersonRockville$13K
Akachimere UzosikeBaltimore$12K
James MurphyGlen Burnie$2K
Andrew SiekanowiczSilver Spring$2K
Benjamin KnoxEaston$2K
Olumuyiwa PaulGlenn Dale$1K
Mark PfaffElkton$1K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →